Increased apoptosis in patients with major depression: A preliminary study

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 533-534

  Eilat, Eran ^b   Mendlovic, Shlomo ^a   Doron, Adiel ^a   Zakuth, Vera ^b   Spirer, Zvi ^b  

^a SHALVATA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DEPRESSION; HUMAN; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; APOPTOSIS; DEPRESSION; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; SUICIDE;

EID: 0033168594     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Carson, D. A., and J. M. Ribereiro 1993. Apoptosis and disease. Lancet 341: 1251.
2. Kerr, J. F. R., C. M. Winterford, and B. V. Harmon. 1994. Apoptosis: its significance in cancer and cancer chemotherapy. Cancer 73:2013.
3. Bestow, J. 1990. Depression and suicide. Pharmacopsychiatry 23:3.
4. Herbert, T. B., and S. Cohen. 1993. Depression and immunity: a meta-analytic review. Psychol. Bull. 113:472.
5. Mendelovic, S., A. Doron, and E. Eilat. 1997. Can depressive patients exploit the immune system for suicide? Med Hypotheses 49:445.
6. Uzunova, V., Y. Sheline, J. M. Davis, A. Rasmusson, D. P. Uzunov, E. Costa, and A. Guidotti. 1998. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA 95:3239.
7. De La Rocque, L., M. M. Campos, B. Olej, F. Castilho, I. F. Mediano, and V. M. Rumjanek. 1995. Inhibition of human LAK-cell activity by the antidepressant trifluoperazine. Immunopharmacology 29:1.
8. Ferlini, C., A. Kunkl, G. Scambia, and A. Fattorossi. 1997. The use of Apostain in identifying early apoptosis. J. Immunol. Methods 203:95.
9. Bauer, M. E., G. J. Gauer, C. Luz, R. O. Silveira, N. B. Nardi, and C. A. von Muhlen. 1995. Evaluation of immune parameters in depressed patients. Life Sci. 57:665.
10. Caldwell, C. L., M. Irwin, and J. Lohr 1991. Reduced natural killer cell cytotoxicity in depression but not schizophrenia. Biol. Psychiatry 30:1131.
11. Schleifer, S. J., S. E. Keller, J. A. Bartlett, H. M. Eckholdt, and B. R. Delaney. 1996. Immunity in young adults with major depressive disorder. Am. J. Psychiatry 153:477.
12. Anesi, A., D. Franciotta, E. Di-Paolo, E. Zardini, G. V. Melzi-d'Eril, and F. Zerbi. 1994. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depression disorders. Funct. Neurol. 9:17.
13. Maes, M. 1995. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuro-psychopharmacol. Biol. Psychiatry 19:11.
14. Maes, M., S. Scharpe, H. Y. Meltzer, E. Bosmans, E. Suy, J. Calabrese, and P. Cosyns. 1993.Relationship between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 49:11.
15. Haggerty, J. J., S. G. Silva, M. Marquardt, G. A. Mason, H. Y. Chang, D. L. Evans, R. N. Golden, and C. Pedersen. 1997. Prevalence of antithyroid Abs in mood disorders. Depress. Anxiety 5:91.
16. Maes, M., E. Bosmans, E. Suy, C. Vandervorst, C. Dejonckheere, and J. Raus. 1991. Antiphospholipid, antinuclear, Epstein-Barr, and cytomegalovirus Abs, and soluble interleukin-2 receptors in depressive patients. J. Affect. Disord. 21:133.
17. Zisook, S., S. R. Shuchter, M. Irwin, D. F. Darko, P. Sledge, and K. Resovsky. 1994. Bereavement, depression, and immune function. Psychiatry Res. 52:1.
18. Irwin, M., U. Lacher, and C. Caidwell. 1992. Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol. Med. 22:1045.